Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results January 9, 2018 Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Europe Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms October 27, 2017 Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Australia Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms October 5, 2017 Relmada Therapeutics Announces $6.9 Million Private Placement June 28, 2017 Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program June 21, 2017 Dr. Ottavio Vitolo Appointed Executive Clinical Advisor at Relmada Therapeutics June 15, 2017 Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors May 18, 2017 Relmada Therapeutics Announces Settlement of Legal Action with Laidlaw & Company April 13, 2017 Relmada Announces FDA Fast Track Designation for d-Methadone for Adjunctive Treatment of Major Depressive Disorder February 15, 2017 Relmada Therapeutics to Participate in the 2nd Annual Disruptive Growth & Healthcare Conference February 13, 2017 Relmada Therapeutics to Participate in BIO CEO and Investor Conference «...151617181920...»
